Navigation Links
Gateway Genomics SneakPeek Noninvasive Prenatal Test (NIPT) Identifies Gender with Cell-free Fetal DNA from Microvolumes of Self-collected Maternal Blood
Date:5/2/2019

Gateway Genomics, a leading developer of genomic tests that give families insight into their future children, announces a new publication titled, “Self-Collection of Maternal Blood for Fetal Sex Determination Using Cell-Free DNA” in the journal of Pregnancy and Child Health. Previous studies had only shown early gender determination using venous blood. When translated into practice, this meant women had to travel to licensed phlebotomists to have their blood drawn intravenously, which limited access to noninvasive prenatal tests. The new paper opens the possibility for women to self-collect as little as 7-10 drops of blood from a finger stick in the comfort of their home and learn the gender of their unborn baby. In this study, fetal sex was determined with 100% accuracy.

While many noninvasive prenatal tests screen for disease states that require physicians to explain the intricate results, Gateway Genomics’ SneakPeek Early Gender DNA Test is designed to specifically focus on fetal sex and return just one answer – male or female. This enables the test to be run on magnitudes smaller volumes of blood than the typical NIPT. When self-collected maternal blood samples arrive at SneakPeek Labs, extracted cell-free fetal DNA is run through real-time quantitative PCR to detect male Y-chromosome DNA, with sensitivity down to a single copy of the Y chromosome. If male Y-chromosome DNA is detected, the result is a boy. If it’s not detected, the baby is a girl. The test is run in approximately 3 hours with up to 100% accuracy.

In this publication, women followed written instructions to collect their own blood samples using small lancets. The average time for blood collection was 5 minutes, and gender results were shown to be 100% accurate.

“In a previous study with 241 participants, we found that the SneakPeek test was 99.6% accurate as early as 9 weeks into pregnancy using intravenous blood,” says Gateway Genomics CEO, Chris Jacob. “This study takes it one step further and shows that results can be just as accurate with only 7-10 drops of self-collected blood from a finger stick. This opens the door for convenient at-home testing, where women can choose to learn the gender of their baby from the ease and privacy of their home and be as confident in the results as at a doctor’s office.”

SneakPeek Early Gender DNA Test is an easy-to-use at-home test to discover a baby’s gender as early as 9 weeks into pregnancy. The test kit is sent via mail to the mother’s home, and a self-collected blood sample is returned to SneakPeek Labs in a prepaid envelope. Gender results are emailed directly, as early as the following day.

About Gateway Genomics

Gateway Genomics is a personal genomics company with a mission to develop leading-edge genetic tests that give families a new level of understanding about their future children. Since inception, more than 100,000 SneakPeek Early Gender DNA tests have been provided to help new moms bond with their babies, make plans, and connect with friends and family around them. Gateway Genomics is located in La Jolla, CA.

Read the full story at https://www.prweb.com/releases/gateway_genomics_sneakpeek_noninvasive_prenatal_test_nipt_identifies_gender_with_cell_free_fetal_dna_from_microvolumes_of_self_collected_maternal_blood/prweb16276562.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. ImageWare Systems Provides Next Generation Cloud Identity Management and Authentication Services to Global Payouts MoneyTracTM Consolidated Payment Gateway
2. Murrieta Genomics To Sponsor SBIR/STTR Workshop - Entrepreneurs to Learn About “America’s Seed Fund”
3. Murrieta Genomics Welcomes Second Genomic Sequencing Incubator Company
4. Karius Announces the Clinical Investigator Award for Applied Pediatric Infectious Disease Genomics
5. Genomics Firm Nabsys Completes Financial Restructuring and Reinstates Technical Leadership Team
6. Newborn Screening Ontario Inks Deal with Tute Genomics, UNIConnect Team to Deliver Informatics Infrastructure for NGS Testing
7. Rubicon Genomics Announces Eurofins Scientific Will Distribute Its Suite of DNA Library Preparation Kits in U.S.
8. Den 10. internationale konference om Genomics (ICG-10) åbner i oktober
9. La 10e International Conference on Genomics (ICG-10) doit souvrir en octobre
10. La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre
11. The 10th International Conference on Genomics (ICG-10) to Open in October
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2020)... , ... February 13, 2020 , ... Murrieta Genomics ... will be hosting a lunch and learn event on February 25th from 11:30 am ... researchers and interested members of the public are invited to attend this free event, ...
(Date:2/13/2020)... ... February 13, 2020 , ... Pharmica Consulting announced ... operations executives and focusing on all facets of clinical trial planning and management. ... engagement, and more. , “We have attended the SCOPE Summit every year ...
(Date:2/11/2020)... ... 11, 2020 , ... Modality Solutions, a leading ... 9001:2015 registration by certification body Intertek. Modality Solutions’ Quality Manager, Hannah Anderson, spearheaded ... existing Standard Operating Procedures (SOPs) and created ten new SOPs. Anderson trained staff ...
Breaking Biology News(10 mins):
(Date:1/24/2020)... ... January 24, 2020 , ... The impact ... biotechnology, diagnostics, therapeutics, laboratory and clinical services during the first two decades of ... world. And as Slone Partners celebrates its 20th anniversary this year, ...
(Date:1/23/2020)... ... January 22, 2020 , ... Ideal Implant CEO ... industry at two recent North American investor forums specializing in medical advancements. New ... Technologies & Diagnostics Forum on November 21, 2019 in New York City, and ...
(Date:1/22/2020)... ... 21, 2020 , ... Microbial Discovery Group LLC (MDG) is ... and Institutional (I&I) Account Manager. Darrell will focus on servicing MDG’s partners with ... 30 years of sales experience working across multiple different market sectors such as; ...
(Date:1/22/2020)... ... January 21, 2020 , ... QCDx , a private ... a simple blood draw, today announced the sale of the proprietary RareScope™ instrument to ... will be used in clinical cancer research. , “The RareScope can detect and isolate ...
Breaking Biology Technology: